Since 1971, the landscape of drug research in the United States has been drastically altered, with severe restrictions placed on the study of substances deemed “most dangerous.” The Controlled Substances Act (CSA), ostensibly implemented for public protection, has instead created a system that inadvertently benefits pharmaceutical companies by maintaining their monopoly on drug manufacturing and distribution.
By Charles Bukowski Warming up Blue Mongoose on the backstretch before the last race, Larry…
By Dakika Esrael Far far across the valley comes the sound of an almighty procession…
By Craig Stevens Illegal drugs and their transport are constantly evolving. Cocaine and weed shipments…
Track and field phenomenon Sha’Carri Richardson on Saturday qualified for the 2024 Olympics, three years…
The Portland Pickles—a collegiate summer baseball wooden bat team based in Portland, Oregon—will become the…
In a groundbreaking decision, the U.S. Court of Appeals for the Ninth Circuit has ruled…